Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Cell-Free DNA (cf-DNA) Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Cell-Free DNA (cf-DNA) Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Donor-derived
Circulating
Cell-free
Segmented by End User/Segment
Oncology
Gynecology
Transplantation
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Trovagene
Sequenom
Roche
Quest Diagnostics
Natera
Invited
Illumania
Guardant Health
CareDx
Biodesix
Biocept
Allenex
Agilent Technology
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Cell-Free DNA (cf-DNA) Testing Market Status and Forecast (2016-2027)
1.3.2 Global Cell-Free DNA (cf-DNA) Testing Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Cell-Free DNA (cf-DNA) Testing Supply by Company
2.1 Global Cell-Free DNA (cf-DNA) Testing Sales Value by Company
2.2 Cell-Free DNA (cf-DNA) Testing Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Cell-Free DNA (cf-DNA) Testing Market Status by Category
3.1 Cell-Free DNA (cf-DNA) Testing Category Introduction
3.1.1 Donor-derived
3.1.2 Circulating
3.1.3 Cell-free
3.2 Global Cell-Free DNA (cf-DNA) Testing Market by Category
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Cell-Free DNA (cf-DNA) Testing Market Status by End User/Segment
4.1 Cell-Free DNA (cf-DNA) Testing Segment by End User/Segment
4.1.1 Oncology
4.1.2 Gynecology
4.1.3 Transplantation
4.2 Global Cell-Free DNA (cf-DNA) Testing Market by End User/Segment
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Cell-Free DNA (cf-DNA) Testing Market Status by Region
5.1 Global Cell-Free DNA (cf-DNA) Testing Market by Region
5.2 North America Cell-Free DNA (cf-DNA) Testing Market Status
5.3 Europe Cell-Free DNA (cf-DNA) Testing Market Status
5.4 Asia Pacific Cell-Free DNA (cf-DNA) Testing Market Status
5.5 Central & South America Cell-Free DNA (cf-DNA) Testing Market Status
5.6 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Status
6 North America Cell-Free DNA (cf-DNA) Testing Market Status
6.1 North America Cell-Free DNA (cf-DNA) Testing Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Cell-Free DNA (cf-DNA) Testing Market Status
7.1 Europe Cell-Free DNA (cf-DNA) Testing Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Cell-Free DNA (cf-DNA) Testing Market Status
8.1 Asia Pacific Cell-Free DNA (cf-DNA) Testing Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Cell-Free DNA (cf-DNA) Testing Market Status
9.1 Central & South America Cell-Free DNA (cf-DNA) Testing Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Status
10.1 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Category and by End User/Segment
12.1 Global Cell-Free DNA (cf-DNA) Testing Sales Value Forecast (2022-2027)
12.2 Global Cell-Free DNA (cf-DNA) Testing Forecast by Category
12.3 Global Cell-Free DNA (cf-DNA) Testing Forecast by End User/Segment
13 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Region/Country
13.1 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Trovagene
14.1.1 Company Information
14.1.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.1.3 Trovagene Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Sequenom
14.2.1 Company Information
14.2.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.2.3 Sequenom Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Roche
14.3.1 Company Information
14.3.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.3.3 Roche Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Quest Diagnostics
14.4.1 Company Information
14.4.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.4.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Natera
14.5.1 Company Information
14.5.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.5.3 Natera Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Invited
14.6.1 Company Information
14.6.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.6.3 Invited Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Illumania
14.7.1 Company Information
14.7.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.7.3 Illumania Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Guardant Health
14.8.1 Company Information
14.8.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.8.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 CareDx
14.9.1 Company Information
14.9.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.9.3 CareDx Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Biodesix
14.10.1 Company Information
14.10.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
14.10.3 Biodesix Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Summary: Get latest Market Research Reports on Cell-Free DNA (cf-DNA) Testing. Industry analysis & Market Report on Cell-Free DNA (cf-DNA) Testing is a syndicated market report, published as Dynamics in Post-pandemic Global Cell-Free DNA (cf-DNA) Testing Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Cell-Free DNA (cf-DNA) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.